These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 17207417)

  • 1. Applications of thermo-reversible pluronic F-127 gels in pharmaceutical formulations.
    Escobar-Chávez JJ; López-Cervantes M; Naïk A; Kalia YN; Quintanar-Guerrero D; Ganem-Quintanar A
    J Pharm Pharm Sci; 2006; 9(3):339-58. PubMed ID: 17207417
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro and in vivo release of albumin using a biodegradable MPEG-PCL diblock copolymer as an in situ gel-forming carrier.
    Hyun H; Kim YH; Song IB; Lee JW; Kim MS; Khang G; Park K; Lee HB
    Biomacromolecules; 2007 Apr; 8(4):1093-100. PubMed ID: 17326678
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Syringeable Pluronic-α-cyclodextrin supramolecular gels for sustained delivery of vancomycin.
    Simões SM; Veiga F; Torres-Labandeira JJ; Ribeiro AC; Sandez-Macho MI; Concheiro A; Alvarez-Lorenzo C
    Eur J Pharm Biopharm; 2012 Jan; 80(1):103-12. PubMed ID: 22005155
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Formulation and evaluation of novel controlled release of topical pluronic lecithin organogel of mefenamic acid.
    Jhawat V; Gupta S; Saini V
    Drug Deliv; 2016 Nov; 23(9):3573-3581. PubMed ID: 27494650
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gel and solid matrix systems for the controlled delivery of drug carrier-associated nucleic acids.
    Fattal E; De Rosa G; Bochot A
    Int J Pharm; 2004 Jun; 277(1-2):25-30. PubMed ID: 15158966
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhancing and sustaining the topical ocular delivery of fluconazole using chitosan solution and poloxamer/chitosan in situ forming gel.
    Gratieri T; Gelfuso GM; de Freitas O; Rocha EM; Lopez RF
    Eur J Pharm Biopharm; 2011 Oct; 79(2):320-7. PubMed ID: 21641994
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thixotropic property in pharmaceutical formulations.
    Lee CH; Moturi V; Lee Y
    J Control Release; 2009 Jun; 136(2):88-98. PubMed ID: 19250955
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dose-dependent sustained release of dexamethasone in inner ear cochlear fluids using a novel local delivery approach.
    Wang X; Dellamary L; Fernandez R; Harrop A; Keithley EM; Harris JP; Ye Q; Lichter J; LeBel C; Piu F
    Audiol Neurootol; 2009; 14(6):393-401. PubMed ID: 19923809
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development and characterization of thermosensitive pluronic-based metronidazole in situ gelling formulations for vaginal application.
    Ibrahim el-SA; Ismail S; Fetih G; Shaaban O; Hassanein K; Abdellah NH
    Acta Pharm; 2012 Mar; 62(1):59-70. PubMed ID: 22472449
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro studies of the properties of thermosensitive systems prepared on Pluronic F-127 as vehicles for methotrexate for delivery to solid tumours.
    Pluta J; Karolewicz B
    Polim Med; 2006; 36(3):37-53. PubMed ID: 17190291
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pluronic block copolymers and Pluronic poly(acrylic acid) microgels in oral delivery of megestrol acetate.
    Alakhov V; Pietrzynski G; Patel K; Kabanov A; Bromberg L; Hatton TA
    J Pharm Pharmacol; 2004 Oct; 56(10):1233-41. PubMed ID: 15482637
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development and in vitro evaluation of furosemide transdermal formulations using experimental design techniques.
    Agyralides GG; Dallas PP; Rekkas DM
    Int J Pharm; 2004 Aug; 281(1-2):35-43. PubMed ID: 15288341
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modified thermoresponsive Poloxamer 407 and chitosan sol-gels as potential sustained-release vaccine delivery systems.
    Kojarunchitt T; Baldursdottir S; Dong YD; Boyd BJ; Rades T; Hook S
    Eur J Pharm Biopharm; 2015 Jan; 89():74-81. PubMed ID: 25481034
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [In vitro evaluation of the gels properties prepared on Pluronic F-127 as vehicles for administration prolactin by injection].
    Karolewicz B; Pawlik-Gałczyńska A; Pluta J; Ryszka F
    Polim Med; 2011; 41(2):35-42. PubMed ID: 21866795
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Excipients influence on properites of thermosensitive carriers containing methotrexate].
    Karolewicz B; Pluta J
    Polim Med; 2008; 38(3):3-15. PubMed ID: 19137972
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proniosomes as a drug carrier for transdermal delivery of ketorolac.
    Alsarra IA; Bosela AA; Ahmed SM; Mahrous GM
    Eur J Pharm Biopharm; 2005 Apr; 59(3):485-90. PubMed ID: 15760729
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel gels and their dispersions--oral drug delivery systems for ciclosporin.
    Murdan S; Andrýsek T; Son D
    Int J Pharm; 2005 Aug; 300(1-2):113-24. PubMed ID: 16009515
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Formulation and preliminary in vivo dog studies of a novel drug delivery system for the treatment of periodontitis.
    Kelly HM; Deasy PB; Ziaka E; Claffey N
    Int J Pharm; 2004 Apr; 274(1-2):167-83. PubMed ID: 15072793
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mucoadhesion, hydration and rheological properties of non-aqueous delivery systems (NADS) for the oral cavity.
    Zaman MA; Martin GP; Rees GD
    J Dent; 2008 May; 36(5):351-9. PubMed ID: 18343013
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.